WT1-sensitized T cells
07-055
Phase 1 mab completed
Quick answer
WT1-sensitized T cells for Leukemia is a Phase 1 program (mab) at Atara Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atara Biotherapeutics
- Indication
- Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- completed